COLL - Collegium Pharmaceutical Inc. (COLL) CEO Joe Ciaffoni on Q1 2022 Results - Earnings Call Transcript
Collegium Pharmaceutical, Inc. (COLL) Q1 2022 Earnings Conference Call May 10, 2022 04:30 PM ET Company Participants Alex Dasalla - Head of IR & Corporate Communications Joe Ciaffoni - President and CEO Colleen Tupper - CFO Scott Dreyer - CCO Conference Call Participants David Amsellem - Piper Sandler Lachlan Hanbury-Brown - William Blair Serge Belanger - Needham & Co. Greg Fraser - Truist Securities Brandon Folkes - Cantor Fitzgerald Presentation Operator Greetings, and welcome to Collegium Pharmaceutical, Inc. First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Alex Dasalla. Thank you. Please go ahead. Alex Dasalla Thank you, operator. Welcome to Collegium Pharmaceuticals first quarter 2022 earnings conference call. This is Alex Dasalla, Head of Investor
For further details see:
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2022 Results - Earnings Call Transcript